Condition: Cancer · Adolescent Cancer · Young Adult Cancer · Sponsor: Yale University
The purpose of this study is to design and Beta test the Life at 100.4, an immersive social virtual reality education tool, with an anticipated 5 patient-caregiver-provider triads.Patients at Yale Pediatric Hematology and Oncology with a new oncologic diagnosis and their caregivers will be eligible for enrollment. Investigators will determine the feasibility and acceptability of implementing Life at 100.4 using validated measures.
This description comes directly from the study's public registry record.
Asher Marks, MD · 203-785-4640 · asher.marks@yale.edu
Vidya Puthepura, MD · 203-785-4640 · vidya.puthenpura@yale.edu
Always discuss trial participation with your own doctor first.
| Pediatric Hematology/Oncology Clinic in Smilow Cancer Hospital | New Haven, Connecticut, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07224204